The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.
- Paytm Shares Soar 3% as Subsidiary Completes Acquiring 25% Stake in Seven Tech
- Zen Tech Shares Locked 20% Lower as Q3 Earnings Fail to Impress Investors
- Bharat Heavy Electricals Shares Gain 1% on Securing Rs 6,700 Crore Project
- Welspun Corp Shares Surge 3% on securing Rs 3,000 Crore Orders in US
- Stocks Under F&O Ban: Deepak Nitrite
These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.
Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.